Hyderabad-based biotechnology firm Bharat Biotech has issued a statement confirming that an "adverse event" had taken place during the Phase I trials of its COVID-19 vaccine candidate COVAXIN. The issue had come to light on Saturday after a report in The Economic Times. It was reported that a 35-year-old trial participant with no co-morbidities was hospitalized after receiving the vaccine shot.
source https://www.newsbytesapp.com/news/india/bharat-biotech-s-covaxin-phase-i-trials-had-adverse-event/story
source https://www.newsbytesapp.com/news/india/bharat-biotech-s-covaxin-phase-i-trials-had-adverse-event/story
إرسال تعليق